Omacetaxine (Subcutaneous Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Omacetaxine (Subcutaneous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Synribo

Description

Omacetaxine injection is used to treat chronic or accelerated phase chronic myeloid leukemia (CML). It is used in patients who have already received medicines for CML that did not work well. Leukemia is a type of cancer where the body makes abnormal white blood cells.

Omacetaxine is an antineoplastic (cancer) medicine. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal cells may also be affected by omacetaxine, other side effects can occur. Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of using it.

This medicine is to be given only by or under the direct supervision of a doctor.

This product is available in the following dosage forms:

  • Powder for Solution
Before Using
DR603699 Portions of this document last updated: Dec. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger